ID   CASP3_RAT               Reviewed;         277 AA.
AC   P55213; P70543; P97699; Q62993;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   02-OCT-2024, entry version 199.
DE   RecName: Full=Caspase-3;
DE            Short=CASP-3;
DE            EC=3.4.22.56;
DE   AltName: Full=Apopain;
DE   AltName: Full=Cysteine protease CPP32;
DE            Short=CPP-32;
DE   AltName: Full=IRP;
DE   AltName: Full=LICE;
DE   AltName: Full=Protein Yama;
DE   AltName: Full=SREBP cleavage activity 1;
DE            Short=SCA-1;
DE   Contains:
DE     RecName: Full=Caspase-3 subunit p17;
DE   Contains:
DE     RecName: Full=Caspase-3 subunit p12;
DE   Flags: Precursor;
GN   Name=Casp3; Synonyms=Cpp32;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8761296;
RA   Juan T.S.-C., McNiece I.K., Jenkins N.A., Gilbert D.J., Copeland N.G.,
RA   Fletcher F.A.;
RT   "Molecular characterization of mouse and rat CPP32 beta gene encoding a
RT   cysteine protease resembling interleukin-1 beta converting enzyme and CED-
RT   3.";
RL   Oncogene 13:749-755(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=9030616; DOI=10.1523/jneurosci.17-05-01561.1997;
RA   Ni B., Wu X., Du Y., Su Y., Hamilton-Byrd E., Rockey P.K., Rosteck P. Jr.,
RA   Poirier G.G., Paul S.M.;
RT   "Cloning and expression of a rat brain interleukin-1beta-converting enzyme
RT   (ICE)-related protease (IRP) and its possible role in apoptosis of cultured
RT   cerebellar granule neurons.";
RL   J. Neurosci. 17:1561-1569(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-264.
RA   Yakovlev A.G.;
RT   "Cloning of the rat cysteine protease p32-beta.";
RL   Submitted (JUN-1996) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 30-241.
RC   TISSUE=Ovary;
RX   PubMed=7588240; DOI=10.1210/endo.136.11.7588240;
RA   Flaws J.A., Kugu K., Trbovich A.M., Desanti A., Tilly K.I.,
RA   Hirshfield A.N., Tilly J.L.;
RT   "Interleukin-1 beta-converting enzyme-related proteases (IRPs) and
RT   mammalian cell death: dissociation of IRP-induced oligonucleosomal
RT   endonuclease activity from morphological apoptosis in granulosa cells of
RT   the ovarian follicle.";
RL   Endocrinology 136:5042-5053(1995).
CC   -!- FUNCTION: Involved in the activation cascade of caspases responsible
CC       for apoptosis execution. At the onset of apoptosis, it proteolytically
CC       cleaves poly(ADP-ribose) polymerase PARP1 at a '216-Asp-|-Gly-217'
CC       bond. Cleaves and activates sterol regulatory element binding proteins
CC       (SREBPs) between the basic helix-loop-helix leucine zipper domain and
CC       the membrane attachment domain. Cleaves and activates caspase-6, -7 and
CC       -9 (CASP6, CASP7 and CASP9, respectively). Cleaves and inactivates
CC       interleukin-18 (IL18). Triggers cell adhesion in sympathetic neurons
CC       through RET cleavage (By similarity). Cleaves IL-1 beta between an Asp
CC       and an Ala, releasing the mature cytokine which is involved in a
CC       variety of inflammatory processes (By similarity). Cleaves and inhibits
CC       serine/threonine-protein kinase AKT1 in response to oxidative stress.
CC       Acts as an inhibitor of type I interferon production during virus-
CC       induced apoptosis by mediating cleavage of antiviral proteins CGAS,
CC       IRF3 and MAVS, thereby preventing cytokine overproduction. Also
CC       involved in pyroptosis by mediating cleavage and activation of
CC       gasdermin-E (GSDME) (By similarity). Cleaves XRCC4 and phospholipid
CC       scramblase proteins XKR4, XKR8 and XKR9, leading to promote
CC       phosphatidylserine exposure on apoptotic cell surface (By similarity).
CC       Cleaves BIRC6 following inhibition of BIRC6-caspase binding by
CC       DIABLO/SMAC (By similarity). {ECO:0000250|UniProtKB:P42574,
CC       ECO:0000250|UniProtKB:P70677}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Strict requirement for an Asp residue at positions P1 and P4.
CC         It has a preferred cleavage sequence of Asp-Xaa-Xaa-Asp-|- with a
CC         hydrophobic amino-acid residue at P2 and a hydrophilic amino-acid
CC         residue at P3, although Val or Ala are also accepted at this
CC         position.; EC=3.4.22.56; Evidence={ECO:0000250|UniProtKB:P42574};
CC   -!- ACTIVITY REGULATION: Inhibited by BIRC6; following inhibition of BIRC6-
CC       caspase binding by DIABLO/SMAC, BIRC6 is subjected to caspase cleavage,
CC       leading to an increase in active caspases.
CC       {ECO:0000250|UniProtKB:P42574}.
CC   -!- SUBUNIT: Heterotetramer that consists of two anti-parallel arranged
CC       heterodimers, each one formed by a 17 kDa (p17) and a 12 kDa (p12)
CC       subunit. Interacts with BIRC6/bruce. {ECO:0000250|UniProtKB:P42574}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P42574}.
CC   -!- TISSUE SPECIFICITY: Expressed in heart, brain, liver, and muscle but
CC       not in kidney or testis.
CC   -!- DEVELOPMENTAL STAGE: Highly expressed in neuron-enriched regions of the
CC       developing brain, but down-regulated to low levels in the adult brain.
CC   -!- PTM: Cleavage by granzyme B, caspase-6, caspase-8 and caspase-10
CC       generates the two active subunits. Additional processing of the
CC       propeptides is likely due to the autocatalytic activity of the
CC       activated protease. Active heterodimers between the small subunit of
CC       caspase-7 protease and the large subunit of caspase-3 also occur and
CC       vice versa. {ECO:0000250|UniProtKB:P42574}.
CC   -!- PTM: S-nitrosylated on its catalytic site cysteine in unstimulated cell
CC       lines and denitrosylated upon activation of the Fas apoptotic pathway,
CC       associated with an increase in intracellular caspase activity. Fas
CC       therefore activates caspase-3 not only by inducing the cleavage of the
CC       caspase zymogen to its active subunits, but also by stimulating the
CC       denitrosylation of its active site thiol.
CC       {ECO:0000250|UniProtKB:P42574}.
CC   -!- PTM: Ubiquitinated by BIRC6; this activity is inhibited by DIABLO/SMAC.
CC       {ECO:0000250|UniProtKB:P42574}.
CC   -!- SIMILARITY: Belongs to the peptidase C14A family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U49930; AAC52765.1; -; mRNA.
DR   EMBL; U84410; AAB41792.1; -; mRNA.
DR   EMBL; BC081854; AAH81854.1; -; mRNA.
DR   EMBL; U58656; AAB02722.1; -; mRNA.
DR   EMBL; U34685; AAC52261.1; -; mRNA.
DR   PIR; I67437; I67437.
DR   RefSeq; NP_037054.1; NM_012922.2.
DR   RefSeq; XP_006253192.1; XM_006253130.3.
DR   AlphaFoldDB; P55213; -.
DR   SMR; P55213; -.
DR   BioGRID; 247437; 1.
DR   ELM; P55213; -.
DR   IntAct; P55213; 1.
DR   MINT; P55213; -.
DR   STRING; 10116.ENSRNOP00000014096; -.
DR   ChEMBL; CHEMBL1075185; -.
DR   MEROPS; C14.003; -.
DR   iPTMnet; P55213; -.
DR   PhosphoSitePlus; P55213; -.
DR   jPOST; P55213; -.
DR   PaxDb; 10116-ENSRNOP00000014096; -.
DR   DNASU; 25402; -.
DR   Ensembl; ENSRNOT00000014095.6; ENSRNOP00000014096.3; ENSRNOG00000010475.6.
DR   Ensembl; ENSRNOT00055019386; ENSRNOP00055015619; ENSRNOG00055011427.
DR   Ensembl; ENSRNOT00060012174; ENSRNOP00060009190; ENSRNOG00060007399.
DR   Ensembl; ENSRNOT00065025146; ENSRNOP00065019686; ENSRNOG00065015182.
DR   GeneID; 25402; -.
DR   KEGG; rno:25402; -.
DR   AGR; RGD:2275; -.
DR   CTD; 836; -.
DR   RGD; 2275; Casp3.
DR   eggNOG; KOG3573; Eukaryota.
DR   GeneTree; ENSGT00940000153232; -.
DR   HOGENOM; CLU_036904_2_0_1; -.
DR   InParanoid; P55213; -.
DR   OMA; MVTERHA; -.
DR   OrthoDB; 2873736at2759; -.
DR   PhylomeDB; P55213; -.
DR   TreeFam; TF102023; -.
DR   BRENDA; 3.4.22.56; 5301.
DR   Reactome; R-RNO-111459; Activation of caspases through apoptosome-mediated cleavage.
DR   Reactome; R-RNO-111465; Apoptotic cleavage of cellular proteins.
DR   Reactome; R-RNO-111469; SMAC, XIAP-regulated apoptotic response.
DR   Reactome; R-RNO-140342; Apoptosis induced DNA fragmentation.
DR   Reactome; R-RNO-2028269; Signaling by Hippo.
DR   Reactome; R-RNO-205025; NADE modulates death signalling.
DR   Reactome; R-RNO-264870; Caspase-mediated cleavage of cytoskeletal proteins.
DR   Reactome; R-RNO-351906; Apoptotic cleavage of cell adhesion proteins.
DR   Reactome; R-RNO-418889; Caspase activation via Dependence Receptors in the absence of ligand.
DR   Reactome; R-RNO-449836; Other interleukin signaling.
DR   Reactome; R-RNO-5620971; Pyroptosis.
DR   PRO; PR:P55213; -.
DR   Proteomes; UP000002494; Chromosome 16.
DR   Bgee; ENSRNOG00000010475; Expressed in duodenum and 20 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0031264; C:death-inducing signaling complex; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; ISO:RGD.
DR   GO; GO:0004861; F:cyclin-dependent protein serine/threonine kinase inhibitor activity; ISO:RGD.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; ISO:RGD.
DR   GO; GO:0097153; F:cysteine-type endopeptidase activity involved in apoptotic process; ISS:UniProtKB.
DR   GO; GO:0097199; F:cysteine-type endopeptidase activity involved in apoptotic signaling pathway; ISS:UniProtKB.
DR   GO; GO:0097200; F:cysteine-type endopeptidase activity involved in execution phase of apoptosis; ISS:UniProtKB.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IDA:RGD.
DR   GO; GO:0005123; F:death receptor binding; IPI:RGD.
DR   GO; GO:0004175; F:endopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0008047; F:enzyme activator activity; IBA:GO_Central.
DR   GO; GO:0008233; F:peptidase activity; ISO:RGD.
DR   GO; GO:0016005; F:phospholipase A2 activator activity; IMP:RGD.
DR   GO; GO:0002020; F:protease binding; IPI:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0061713; P:anterior neural tube closure; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0007413; P:axonal fasciculation; IMP:RGD.
DR   GO; GO:0001782; P:B cell homeostasis; ISO:RGD.
DR   GO; GO:0045165; P:cell fate commitment; ISO:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0072734; P:cellular response to staurosporine; ISO:RGD.
DR   GO; GO:0006974; P:DNA damage response; ISO:RGD.
DR   GO; GO:1904019; P:epithelial cell apoptotic process; ISO:RGD.
DR   GO; GO:0030218; P:erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0097194; P:execution phase of apoptosis; ISO:RGD.
DR   GO; GO:0044346; P:fibroblast apoptotic process; ISO:RGD.
DR   GO; GO:0034349; P:glial cell apoptotic process; IEP:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0021766; P:hippocampus development; IEP:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IMP:RGD.
DR   GO; GO:0097193; P:intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0008627; P:intrinsic apoptotic signaling pathway in response to osmotic stress; ISO:RGD.
DR   GO; GO:0030216; P:keratinocyte differentiation; ISO:RGD.
DR   GO; GO:0007611; P:learning or memory; IMP:RGD.
DR   GO; GO:0071887; P:leukocyte apoptotic process; IEP:RGD.
DR   GO; GO:0001554; P:luteolysis; IEP:RGD.
DR   GO; GO:0046007; P:negative regulation of activated T cell proliferation; ISO:RGD.
DR   GO; GO:0030889; P:negative regulation of B cell proliferation; ISO:RGD.
DR   GO; GO:0045786; P:negative regulation of cell cycle; ISO:RGD.
DR   GO; GO:0001818; P:negative regulation of cytokine production; ISO:RGD.
DR   GO; GO:0051402; P:neuron apoptotic process; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; IEP:RGD.
DR   GO; GO:0048011; P:neurotrophin TRK receptor signaling pathway; ISO:RGD.
DR   GO; GO:1902004; P:positive regulation of amyloid-beta formation; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0140639; P:positive regulation of pyroptotic inflammatory response; ISO:RGD.
DR   GO; GO:0030163; P:protein catabolic process; IDA:RGD.
DR   GO; GO:0051604; P:protein maturation; ISO:RGD.
DR   GO; GO:0016485; P:protein processing; ISO:RGD.
DR   GO; GO:0006508; P:proteolysis; IDA:UniProtKB.
DR   GO; GO:0070269; P:pyroptotic inflammatory response; ISO:RGD.
DR   GO; GO:0031647; P:regulation of protein stability; IDA:UniProtKB.
DR   GO; GO:0098693; P:regulation of synaptic vesicle cycle; ISO:RGD.
DR   GO; GO:0043200; P:response to amino acid; IEP:RGD.
DR   GO; GO:0032025; P:response to cobalt ion; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IEP:RGD.
DR   GO; GO:0009749; P:response to glucose; IDA:RGD.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IDA:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0010038; P:response to metal ion; IEP:RGD.
DR   GO; GO:0035094; P:response to nicotine; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0009411; P:response to UV; ISO:RGD.
DR   GO; GO:0009611; P:response to wounding; ISO:RGD.
DR   GO; GO:0010165; P:response to X-ray; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0007605; P:sensory perception of sound; ISO:RGD.
DR   GO; GO:0051146; P:striated muscle cell differentiation; IEP:RGD.
DR   GO; GO:0043029; P:T cell homeostasis; ISO:RGD.
DR   CDD; cd00032; CASc; 1.
DR   Gene3D; 3.40.50.1460; -; 1.
DR   InterPro; IPR029030; Caspase-like_dom_sf.
DR   InterPro; IPR033139; Caspase_cys_AS.
DR   InterPro; IPR016129; Caspase_his_AS.
DR   InterPro; IPR011600; Pept_C14_caspase.
DR   InterPro; IPR002138; Pept_C14_p10.
DR   InterPro; IPR001309; Pept_C14_p20.
DR   InterPro; IPR015917; Pept_C14A.
DR   PANTHER; PTHR10454; CASPASE; 1.
DR   PANTHER; PTHR10454:SF198; CASPASE-3; 1.
DR   Pfam; PF00656; Peptidase_C14; 1.
DR   PRINTS; PR00376; IL1BCENZYME.
DR   SMART; SM00115; CASc; 1.
DR   SUPFAM; SSF52129; Caspase-like; 1.
DR   PROSITE; PS01122; CASPASE_CYS; 1.
DR   PROSITE; PS01121; CASPASE_HIS; 1.
DR   PROSITE; PS50207; CASPASE_P10; 1.
DR   PROSITE; PS50208; CASPASE_P20; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Apoptosis; Cytoplasm; Hydrolase; Phosphoprotein; Protease;
KW   Reference proteome; S-nitrosylation; Thiol protease; Ubl conjugation;
KW   Zymogen.
FT   PROPEP          1..9
FT                   /evidence="ECO:0000250|UniProtKB:P42574"
FT                   /id="PRO_0000004589"
FT   PROPEP          10..28
FT                   /evidence="ECO:0000250|UniProtKB:P42574"
FT                   /id="PRO_0000004590"
FT   CHAIN           29..175
FT                   /note="Caspase-3 subunit p17"
FT                   /evidence="ECO:0000250|UniProtKB:P42574"
FT                   /id="PRO_0000004591"
FT   CHAIN           176..277
FT                   /note="Caspase-3 subunit p12"
FT                   /evidence="ECO:0000250|UniProtKB:P42574"
FT                   /id="PRO_0000004592"
FT   ACT_SITE        121
FT                   /evidence="ECO:0000250|UniProtKB:P29466"
FT   ACT_SITE        163
FT                   /evidence="ECO:0000250|UniProtKB:P29466"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P42574"
FT   MOD_RES         11
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P70677"
FT   MOD_RES         26
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P42574"
FT   MOD_RES         163
FT                   /note="S-nitrosocysteine; in inhibited form"
FT                   /evidence="ECO:0000250|UniProtKB:P42574"
FT   CONFLICT        25..29
FT                   /note="KSMDS -> QVD (in Ref. 4; AAB02722)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        170
FT                   /note="C -> S (in Ref. 5; AAC52261)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        178
FT                   /note="T -> A (in Ref. 5; AAC52261)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        182
FT                   /note="M -> V (in Ref. 5; AAC52261)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        187
FT                   /note="I -> K (in Ref. 5; AAC52261)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        190
FT                   /note="E -> G (in Ref. 2; AAB41792)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        199
FT                   /note="T -> S (in Ref. 5; AAC52261)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        211
FT                   /note="D -> G (in Ref. 5; AAC52261)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        236
FT                   /note="L -> I (in Ref. 4; AAB02722)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        245
FT                   /note="T -> M (in Ref. 2; AAB41792)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   277 AA;  31492 MW;  ADABF418E2507402 CRC64;
     MDNNETSVDS KSINNFETKT IHGSKSMDSG IYLDSSYKMD YPEMGLCIII NNKNFHKSTG
     MSARNGTDVD AANLRETFMA LKYEVRNKND LTREEIMELM DSVSKEDHSK RSSFVCVILS
     HGDEGVIFGT NGPVDLKKLT SFFRGDYCRS LTGKPKLFII QACRGTELDC GIETDSGTDD
     DMACQKIPVE ADFLYAYSTA PGYYSWRNSR DGSWFIQSLC AMLKLYAHKL EFMHILTRVN
     RKVATEFESF SLDATFHAKK QIPCIVSMLT KELYFYH
//
